{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:34:01Z","timestamp":1761057241862,"version":"3.41.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1-3","license":[{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,11,1]],"date-time":"1998-11-01T00:00:00Z","timestamp":909878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1998,11]]},"DOI":"10.1023\/a:1006154900130","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:53:09Z","timestamp":1040518389000},"page":"29-41","source":"Crossref","is-referenced-by-count":41,"title":["Prognostic implications of expression of the cell cycle inhibitor protein p27Kip1"],"prefix":"10.1007","volume":"52","author":[{"given":"Sandrine","family":"Cariou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Catzavelos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joyce M.","family":"Slingerland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"201164_CR1","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/0955-0674(93)90100-5","volume":"5","author":"MJ Solomon","year":"1993","unstructured":"Solomon MJ: Activation of the various cyclin\/cdc2 proteins. Current Opinions in Cell Biology 5:180-186, 1993","journal-title":"Current Opinions in Cell Biology"},{"key":"201164_CR2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/374131a0","volume":"374","author":"DO Morgan","year":"1995","unstructured":"Morgan DO: Principles of Cdk regulation. Nature 374:131-134, 1995","journal-title":"Nature"},{"key":"201164_CR3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0092-8674(94)90540-1","volume":"79","author":"CJ Sherr","year":"1994","unstructured":"Sherr CJ: G1 phase progression: cycling on cue. Cell 79:551-555, 1994","journal-title":"Cell"},{"key":"201164_CR4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1101\/gad.9.10.1149","volume":"9","author":"CJ Sherr","year":"1995","unstructured":"Sherr CJ, Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9:1149-1163, 1995","journal-title":"Genes Dev"},{"key":"201164_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1242\/jcs.1994.Supplement_18.10","volume":"18","author":"SI Reed","year":"1994","unstructured":"Reed SI, Bailly E, Dulic V, Hengst L, Resnitzky D, Slingerland J: G1 control in mammalian cells. J Cell Sci Suppl 18:69-73, 1994","journal-title":"J Cell Sci Suppl"},{"key":"201164_CR6","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/359599a0","volume":"359","author":"AW Murray","year":"1992","unstructured":"Murray AW: Creative blocks: cell cycle checkpoints and feedback controls. Nature 359:599-604, 1992","journal-title":"Nature"},{"key":"201164_CR7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0092-8674(92)90586-2","volume":"71","author":"L Hartwell","year":"1992","unstructured":"Hartwell L: Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells. Cell 71:543-546, 1992","journal-title":"Cell"},{"key":"201164_CR8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(93)90500-P","volume":"75","author":"WS El-Deiry","year":"1993","unstructured":"El-Deiry WS, Tokino T, Velculescu VE, Levy D, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor supression. Cell 75:817-825, 1993","journal-title":"Cell"},{"key":"201164_CR9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/366707a0","volume":"366","author":"Y Gu","year":"1993","unstructured":"Gu Y, Turck CW, Morgan DO: Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707-710, 1993","journal-title":"Nature"},{"key":"201164_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0092-8674(93)90499-G","volume":"75","author":"JW Harper","year":"1993","unstructured":"Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependant kinases. Cell 75:805-816, 1993","journal-title":"Cell"},{"key":"201164_CR11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/excr.1994.1063","volume":"211","author":"A Noda","year":"1994","unstructured":"Noda A, Ning Y, Venable SF, Pereira-Smith OM, Smith JR: Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 211:90-98, 1994","journal-title":"Exp Cell Res"},{"key":"201164_CR12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1101\/gad.8.1.9","volume":"8","author":"K Polyak","year":"1994","unstructured":"Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A: p27Kipl, a cyclin-Cdk inhibitor, links transforming growth factor-\u03b2 and contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994","journal-title":"Genes Dev"},{"key":"201164_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0092-8674(94)90572-X","volume":"78","author":"C Polyak","year":"1994","unstructured":"Polyak C, Lee M-H, Erdjument-Romage H, Koff A, Roberts J, Tempst P, Massague J: Cloning of p27-KIP1 a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66, 1994","journal-title":"Cell"},{"key":"201164_CR14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0092-8674(94)90573-8","volume":"78","author":"H Toyoshima","year":"1994","unstructured":"Toyoshima H, Hunter T: p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994","journal-title":"Cell"},{"key":"201164_CR15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1101\/gad.9.6.639","volume":"9","author":"M-H Lee","year":"1995","unstructured":"Lee M-H, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with a unique domain structure and tissue distribution. Genes Dev 9:639-649, 1995","journal-title":"Genes Dev"},{"key":"201164_CR16","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1101\/gad.9.6.650","volume":"9","author":"S Matsuoka","year":"1995","unstructured":"Matsuoka S, Edwards MC, Bai C, Parker S, Zhang P, Baldini A, Harper JW, Elledge SJ: p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 9:650-662, 1995","journal-title":"Genes Dev"},{"key":"201164_CR17","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1126\/science.7863329","volume":"267","author":"SB Parker","year":"1995","unstructured":"Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olsen EN, Harper JW, Elledge SJ: p53-independent expression of p21CIP1 in muscle and other terminally differentiating cells. Science 267:1024-1028, 1995","journal-title":"Science"},{"key":"201164_CR18","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1126\/science.7863328","volume":"267","author":"SX Skapek","year":"1995","unstructured":"Skapek SX, Rhee J, Spicer DB, Lassar AB: Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 267:1022-1024, 1995","journal-title":"Science"},{"key":"201164_CR19","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1126\/science.7863327","volume":"267","author":"O Halevy","year":"1995","unstructured":"Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon G, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018-1022, 1995","journal-title":"Science"},{"key":"201164_CR20","doi-asserted-by":"crossref","first-page":"8655","DOI":"10.1073\/pnas.91.18.8655","volume":"91","author":"H Flores-Rosas","year":"1994","unstructured":"Flores-Rosas H, Kelman Z, Dean FB, Pan Z, Harper JW, Elledge SJ, O'Donnell M, Hurwitz J: Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase \u03b4 holoenzyme. Proc Natl Acad Sci USA 91:8655-8659, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"201164_CR21","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/371534a0","volume":"371","author":"R Li","year":"1994","unstructured":"Li R, Waga S, Hannon G, Beach D, Stillman B: Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 371:534-537, 1994","journal-title":"Nature"},{"key":"201164_CR22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/369574a0","volume":"369","author":"S Waga","year":"1994","unstructured":"Waga S, Hannon GJ, Beach D, Stillman B: The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578, 1994","journal-title":"Nature"},{"key":"201164_CR23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0092-8674(94)90379-4","volume":"76","author":"V Dulic","year":"1994","unstructured":"Dulic V, Kaufman WK, Wilson SJ, Tosty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013-1023, 1994","journal-title":"Cell"},{"key":"201164_CR24","first-page":"1387","volume":"12","author":"T Petrocelli","year":"1996","unstructured":"Petrocelli T, Poon R, Drucker D, Slingerland J, Rosen C: UVB irradiation induces p21Cip1\/WAF1 and mediates G1 and S phase checkpoints. Oncogene 12:1387-1396, 1996","journal-title":"Oncogene"},{"key":"201164_CR25","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.8475385","volume":"260","author":"A Koff","year":"1993","unstructured":"Koff A, Ohtsuki M, Polyak K, Roberts JM, Massague J: Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF-\u03b2. Science 260:536-539, 1993","journal-title":"Science"},{"key":"201164_CR26","first-page":"3683","volume":"14","author":"JM Slingerland","year":"1994","unstructured":"Slingerland JM, Hengst L, Pan C-H, Alexander D, Stampfer MR, Reed SI: A novel inhibitor of cyclin-Cdk activity detected in transforming growth factor \u03b2-arrested epithelial cells. Mol Cell Biol 14:3683-3694, 1994","journal-title":"Mol Cell Biol"},{"key":"201164_CR27","first-page":"4889","volume":"14","author":"EJ Firpo","year":"1994","unstructured":"Firpo EJ, Koff A, Solomon MJ, Roberts JM: Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol Cell Biol 14:4889-4901, 1994","journal-title":"Mol Cell Biol"},{"key":"201164_CR28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF01275210","volume":"34","author":"EJ Bernhard","year":"1995","unstructured":"Bernhard EJ, Maity A, Muschel RJ, McKenna WG: Effects of ionizing radiation on cell cycle progression. A review. Radiat Environ Biophys 34:79-83, 1995","journal-title":"Radiat Environ Biophys"},{"key":"201164_CR29","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/372570a0","volume":"372","author":"J Nourse","year":"1994","unstructured":"Nourse J, Firpo E, Flanagan WM, Coats S, Polyak K, Lee M-H, Massague J, Crabtree GR, Roberts JM: Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570-573, 1994","journal-title":"Nature"},{"key":"201164_CR30","first-page":"2447","volume":"13","author":"VA Florenes","year":"1996","unstructured":"Florenes VA, Bhattacharya N, Bani MR, Ben-David J, Kerbel RS, Slingerland JM: TGF-\u03b2 mediated G1 arrest in a human melanoma cell line lacking p15-INK4B: evidence for cooperation between p21Cip1 and p27Kip1. Oncogene 13:2447-2547, 1996","journal-title":"Oncogene"},{"key":"201164_CR31","first-page":"1581","volume":"11","author":"M Hall","year":"1995","unstructured":"Hall M, Bates S, Peters G: Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene 11:1581-1588, 1995","journal-title":"Oncogene"},{"key":"201164_CR32","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1091\/mbc.6.9.1197","volume":"6","author":"R Poon","year":"1995","unstructured":"Poon R, Toyoshima H, Hunter T: Redistribution of the CDK inhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet light. Mol Biol Cell 6:1197-1213, 1995","journal-title":"Mol Biol Cell"},{"key":"201164_CR33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1091\/mbc.6.4.387","volume":"6","author":"JW Harper","year":"1995","unstructured":"Harper JW, Elledge S, Keyomarsi K, Dynlacht B, Tsai L-H, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindell E, Fox MP, Wei N: Inhibition of cyclin-dependent kinases by p21. Mol Biol Cell 6:387-400, 1995","journal-title":"Mol Biol Cell"},{"key":"201164_CR34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/371257a0","volume":"371","author":"GJ Hannon","year":"1994","unstructured":"Hannon GJ, Beach D: p15INK4B is a potential effector of TGF-\u03b2-induced cell cycle arrest. Nature 371:257-261, 1994","journal-title":"Nature"},{"key":"201164_CR35","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","volume":"366","author":"M Serrano","year":"1993","unstructured":"Serrano M, Hannon GJ, Beach D: A new regulatory motif in cell cycle control causing specific inhibition of cyclin D\/Cdk4. Nature 366:704-707, 1993","journal-title":"Nature"},{"key":"201164_CR36","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1101\/gad.8.24.2939","volume":"8","author":"K-L Guan","year":"1994","unstructured":"Guan K-L, Jenkins CW, Li Y, Nichols MA, Wu Y, O'Keefe CL, Matera AG, Xiong Y: Growth suppression by p18, a p16INK4\/MTS1 and p14INK4B\/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev 8:2939-2952, 1994","journal-title":"Genes Dev"},{"key":"201164_CR37","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1128\/MCB.15.5.2682","volume":"15","author":"K-MF Chan","year":"1995","unstructured":"Chan K-MF, Zhang J, Cheng L, Shapiro DN, Winoto A: Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16-INK4. Mol Cell Biol 15:2682-2688, 1995","journal-title":"Mol Cell Biol"},{"key":"201164_CR38","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1128\/MCB.15.5.2672","volume":"15","author":"H Hirai","year":"1995","unstructured":"Hirai H, Roussel MF, Kato J-Y, Ashmun RA, Sherr CJ: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol Cell Biol 15:2672-2681, 1995","journal-title":"Mol Cell Biol"},{"key":"201164_CR39","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1128\/MCB.17.5.2458","volume":"17","author":"C Sandhu","year":"1997","unstructured":"Sandhu C, Garbe J, Daksis J, Pan C-H, Bhattacharya N, Yaswen P, Koh J, Slingerland J, Stampfer MR: TGF-\u03b2 stabilizes p15INK4B protein, increases p15-INK4B\/cdk4 complexes and inhibits cyclin D1\/cdk4 association in human mammary epithelial cells. Mol Cell Biol 17:2458-2467, 1997","journal-title":"Mol Cell Biol"},{"key":"201164_CR40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/j.1460-2075.1995.tb07026.x","volume":"14","author":"D Parry","year":"1995","unstructured":"Parry D, Bates S, Mann DJ, Peters G: Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4\/MTS1 tumour suppressor gene product. EMBO J 14:503-511, 1995","journal-title":"EMBO J"},{"key":"201164_CR41","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.8023167","volume":"265","author":"P Cairns","year":"1994","unstructured":"Cairns P, Mao L, Merlo A, Lee D, Schwab D, Eby Y, Tokino K, van der Riet P, Blaugrund JE, Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265:415-417, 1994","journal-title":"Science"},{"key":"201164_CR42","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng1095-210","volume":"11","author":"P Cairns","year":"1995","unstructured":"Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D, Sidransky D: Frequency of homozygous deletion at p16\/CDKN2 in primary human tumours. Nature Genetics 11:210-212, 1995","journal-title":"Nature Genetics"},{"key":"201164_CR43","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0092-8674(94)90543-6","volume":"79","author":"T Hunter","year":"1994","unstructured":"Hunter T, Pines J: Cyclins and cancer II: Cyclin D and cdk inhibitors come of age. Cell 79:573-582, 1994","journal-title":"Cell"},{"key":"201164_CR44","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/scbi.1995.0010","volume":"6","author":"S Bates","year":"1995","unstructured":"Bates S, Peters G: Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 6:73-82, 1995","journal-title":"Semin Cancer Biol"},{"key":"201164_CR45","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/ng0994-22","volume":"8","author":"A Kanb","year":"1994","unstructured":"Kanb A, Shattuck-Eidens D, Eeles R, Liu Q, Gruis NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergmann W, Frants R, Goldhar DE, Green A, Mac-Lennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA: Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nature Genetics 8:22-26, 1994","journal-title":"Nature Genetics"},{"key":"201164_CR46","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","volume":"368","author":"T Nobori","year":"1994","unstructured":"Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA: Deletions of the cyclin dependent kinase-4 inhibitor in multiple human cancers. Nature 368:753-756, 1994","journal-title":"Nature"},{"key":"201164_CR47","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1073\/pnas.91.12.5291","volume":"91","author":"L Hengst","year":"1994","unstructured":"Hengst L, Dulic V, Slingerland J, Lees E, Reed SI: A cell cycle regulated inhibitor of cyclin dependent kinases. Proc Natl Acad Sci USA 91:5291-5294, 1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"201164_CR48","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0092-8674(94)90257-7","volume":"79","author":"J-Y Kato","year":"1994","unstructured":"Kato J-Y, Matsuoka M, Polyak K, Massague J, Sherr C: Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487-496, 1994","journal-title":"Cell"},{"key":"201164_CR49","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1101\/gad.11.18.2335","volume":"11","author":"P Casaccia-Bonnefil","year":"1997","unstructured":"Casaccia-Bonnefil P, Tikoo R, Kiyokawa H, Friedrich V Jr, Chao MV, Koff A: Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev 11:2335-2346, 1997","journal-title":"Genes Dev"},{"key":"201164_CR50","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/emboj\/16.2.306","volume":"16","author":"B Durand","year":"1997","unstructured":"Durand B, Gao FB, Raff M: Accumulation of the cyclin-dependent kinase inhibitor p27\/Kip1 and the timing of oligodendrocyte differentiation. EMBO J 16:306-317, 1997","journal-title":"EMBO J"},{"key":"201164_CR51","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0092-8674(00)81801-2","volume":"87","author":"H Koyama","year":"1996","unstructured":"Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R: Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell 87:1069-1078, 1996","journal-title":"Cell"},{"key":"201164_CR52","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0092-8674(00)81238-6","volume":"85","author":"H Kiyokawa","year":"1996","unstructured":"Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A: Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1. Cell 85:721-732, 1996","journal-title":"Cell"},{"key":"201164_CR53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0092-8674(00)81237-4","volume":"85","author":"K Nakayama","year":"1996","unstructured":"Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K: Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720, 1996","journal-title":"Cell"},{"key":"201164_CR54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0092-8674(00)81239-8","volume":"85","author":"ML Fero","year":"1996","unstructured":"Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Polyak K, Firpo E, Tsai L, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM: A syndrome of multi-organ hyperplasia with features of gigantism, tumorigenesis and female sterility in p27Kip1-deficient mice. Cell 85:733-744, 1996","journal-title":"Cell"},{"key":"201164_CR55","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1126\/science.7624798","volume":"269","author":"M Pagano","year":"1995","unstructured":"Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M: Role of ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269:682-685, 1995","journal-title":"Science"},{"key":"201164_CR56","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","volume":"271","author":"L Hengst","year":"1996","unstructured":"Hengst L, Reed SI: Translational control of p27Kip1 accumulation during the cell cycle. Science 271:1861-1864, 1996","journal-title":"Science"},{"key":"201164_CR57","doi-asserted-by":"crossref","unstructured":"Pagano M, Beer-Romero P, Glass S, Tam S, Theodoras A, Rolfe M, Draetta G: Targeting ubiquitin-mediated degradation for proliferation inhibitors. Seventh Pezcoller Symposium, Cancer Genes: Functional Aspects, 1995","DOI":"10.1007\/978-1-4615-5895-8_15"},{"key":"201164_CR58","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.1128\/MCB.17.7.3850","volume":"17","author":"H Aktas","year":"1997","unstructured":"Aktas H, Cai H, Cooper GM: Ras links growth factor signalling to the cell cycle machinery via regulation of cyclin D1 and the cdk inhibitor p27Kip1. Mol Cell Biol 17:3850-3857, 1997","journal-title":"Mol Cell Biol"},{"key":"201164_CR59","doi-asserted-by":"crossref","first-page":"5348","DOI":"10.1128\/MCB.17.9.5348","volume":"17","author":"N Takuwa","year":"1997","unstructured":"Takuwa N, Takuwa Y: Ras activity late in G1 phase required for p27kip1 downregulation, passage through the restriction point, and entry into S phase in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol 17:5348-5358, 1997","journal-title":"Mol Cell Biol"},{"key":"201164_CR60","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/sj.onc.1201228","volume":"15","author":"M Kawada","year":"1997","unstructured":"Kawada M, Yamagoe S, Murakami Y, Suzuki K, Mizuno S, Uehara Y: Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway. Oncogene 15:629-637, 1997","journal-title":"Oncogene"},{"key":"201164_CR61","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.leu.2400581","volume":"11","author":"A Alessandrini","year":"1997","unstructured":"Alessandrini A, Chiaur DS, Erikson R, Pagano M: Regulation of the cyclin-depedent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11:342-345, 1997","journal-title":"Leukemia"},{"key":"201164_CR62","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1093\/emboj\/16.17.5334","volume":"16","author":"J Vlach","year":"1997","unstructured":"Vlach J, Hennecke S, Amati B: Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1. EMBO J 16:5334-5344, 1997","journal-title":"EMBO J"},{"key":"201164_CR63","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1101\/gad.11.11.1464","volume":"11","author":"RJ Sheaff","year":"1997","unstructured":"Sheaff RJ, Groudine M, Gordon M, Roberts JM, Clurman BE: Cyclin E-CDK2 is a regulator of p27-Kip1. Genes Dev 11:1464-1478, 1997","journal-title":"Genes Dev"},{"key":"201164_CR64","doi-asserted-by":"crossref","first-page":"6595","DOI":"10.1002\/j.1460-2075.1996.tb01050.x","volume":"15","author":"J Vlach","year":"1996","unstructured":"Vlach J, Hennecke S, Alevizopoulos K, Conti D, Amati B: Growth arrest by the cyclin-dependent kinase inhibitor p27Kip1 is abrogated by c-Myc. EMBO J 15:6595-6604, 1996","journal-title":"EMBO J"},{"key":"201164_CR65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.136.1.1","volume":"136","author":"RK Assoian","year":"1997","unstructured":"Assoian RK: Anchorage-dependent cell cycle progression. J Cell Biol 136:1-3, 1997","journal-title":"J Cell Biol"},{"key":"201164_CR66","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1083\/jcb.133.2.391","volume":"133","author":"X Zhu","year":"1996","unstructured":"Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK: Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol 133:391-403, 1996","journal-title":"J Cell Biol"},{"key":"201164_CR67","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1126\/science.271.5248.499","volume":"271","author":"FG Fang","year":"1996","unstructured":"Fang FG, Watanabe N, Hunter T, Ruoslahti E: Dependence of cyclin E-cdk2 kinase activity on cell anchorage. Science 271:499-502, 1996","journal-title":"Science"},{"key":"201164_CR68","doi-asserted-by":"crossref","first-page":"13937","DOI":"10.1074\/jbc.272.21.13937","volume":"272","author":"G Radeva","year":"1997","unstructured":"Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J, Dedhar S: Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272:13937-13944, 1997","journal-title":"J Biol Chem"},{"key":"201164_CR69","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1038\/nm1196-1204","volume":"2","author":"B St Croix","year":"1996","unstructured":"St Croix B, Florenes V, Rak A, Flanagan JW, Bhattacharya N, Slingerland JM, Kerbel RS: Impact of the cyclin dependent kinase inhibitor p27Kip1 on adhesion-dependent resistance of tumor cells to anticancer agents. Nature Medicine 2:1204-1210, 1996","journal-title":"Nature Medicine"},{"key":"201164_CR70","first-page":"1206","volume":"55","author":"JA Pietenpol","year":"1995","unstructured":"Pietenpol JA, Bohlander SK, Sato Y, Papadopoulos N, Liu B, Friedman C, Trask BJ, Roberts JM, Kinzler KW, Rowley JD, Vogelstein B: Assignment of human p27\nKip1 gene to 12p13 and its analysis in leukemias. Cancer Res 55:1206-1210, 1995","journal-title":"Cancer Res"},{"key":"201164_CR71","first-page":"1211","volume":"55","author":"MV Ponce-Castaneda","year":"1995","unstructured":"Ponce-Castaneda MV, Lee M-H, Latres E, Polyak K, Lacombe L, Montgomery K, Mathew S, Krauter K, Sheinfeld J, Massague J, Cordon-Cardo C: p27\nKip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumours. Cancer Res 55:1211-1214, 1995","journal-title":"Cancer Res"},{"key":"201164_CR72","first-page":"2266","volume":"55","author":"N Kawamata","year":"1995","unstructured":"Kawamata N, Morosetti R, Miller CW, Park D, Spirin KS, Nakamaki T, Takeuchi S, Hatta Y, Simpson J, Wilczynski S, Young YL, Bartram CR, Koeffler HP: Molecular analysis of the cyclin-dependent kinase inhibitor gene p27\nKip1 in human malignancies. Cancer Res 55:2266-2269, 1995","journal-title":"Cancer Res"},{"key":"201164_CR73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00218840","volume":"97","author":"A Ferrando","year":"1996","unstructured":"Ferrando A, Balbin M, Pendas AM, Vizoso F, Velasco G, Lopez-Otin C: Mutational analysis of the human cyclin-dependent kinase inhibitor p27Kip1 in primary breast carcinomas. Human Genetics 97:91-94, 1996","journal-title":"Human Genetics"},{"key":"201164_CR74","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nm0297-227","volume":"3","author":"C Catzavelos","year":"1997","unstructured":"Catzavelos C, Bhattacharya N, Ung YC, Wilson JA, Roncari L, Sandhu C, Shaw P, Yeger H, Morava-Protzner I, Kapusta L, Franssen E, Pritchard KI, Slingerland JM: Decreased levels of the cell cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nature Medicine 3:227-230, 1997","journal-title":"Nature Medicine"},{"key":"201164_CR75","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nm0297-222","volume":"3","author":"PL Porter","year":"1997","unstructured":"Porter PL, Malone KE, Heagerty PJ, Alexander GM, Gatti LA, Firpo EJ, Daling JR, Roberts JM: Expression of cell cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Medicine 3:222-225, 1997","journal-title":"Nature Medicine"},{"key":"201164_CR76","first-page":"1259","volume":"57","author":"P Tan","year":"1997","unstructured":"Tan P, Cady B, Wanner M, Worland P, Cukor B, Magi-Galluzzi C, Lavin P, Draetta G, Pagano M, Loda M: The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Cancer Res 57:1259-1263, 1997","journal-title":"Cancer Res"},{"key":"201164_CR77","doi-asserted-by":"crossref","first-page":"6380","DOI":"10.1073\/pnas.94.12.6380","volume":"94","author":"S Fredersdorf","year":"1997","unstructured":"Fredersdorf S, Burns J, Milne AM, Packham G, Fallis L, Gillett CE, Royds JA, Peston D, Hall PA, Hanby AM, Barnes DM, Shousha S, O'Hare MJ, Lu X: High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci USA 94:6380-6385, 1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"201164_CR78","first-page":"1879","volume":"3","author":"A Sgambato","year":"1997","unstructured":"Sgambato A, Zhang Y, Arber N, Hibshoosh H, Doki Y, Ciaparrone M, Santella RM, Cittadini A, Weinstein IB: Deregulated expression of p27Kip1 in human breast cancers. Clin Cancer Res 3:1879-1887, 1997","journal-title":"Clin Cancer Res"},{"key":"201164_CR79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nm0297-231","volume":"3","author":"M Loda","year":"1997","unstructured":"Loda M, Cukor B, Tam SW, Lavin P, Fiorentino M, Draetta GF, Jessup JM, Pagano M: Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Medicine 3:231-234, 1997","journal-title":"Nature Medicine"},{"key":"201164_CR80","first-page":"542","volume":"58","author":"J Tsihlias","year":"1998","unstructured":"Tsihlias J, Kapusta LR, DeBoer G, Morava-Protzner I, Zbieranowski I, Bhattacharya N, Catzavelos GC, Klotz LH, Slingerland JM: Loss of cyclin dependent kinase inhibitor p27Kip1 is a novel prognostic factor in localized human prostate adenocarcinoma. Cancer Res 58:542-548, 1998","journal-title":"Cancer Res"},{"key":"201164_CR81","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0022-5347(01)63776-5","volume":"159","author":"RM Yang","year":"1998","unstructured":"Yang RM, Naitoh J, Philipson J, Wang H, deKernion JB, Loda M, Reiter RE: Low levels of p27 protein expression predict poor disease free survival in patients with pathological T2a-T3b adenocarcinoma of the prostate. J Urol 159:941-945, 1998","journal-title":"J Urol"},{"key":"201164_CR82","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nm0697-593","volume":"3","author":"M Mori","year":"1997","unstructured":"Mori M, Mimori K, Shiraishi T, Tanaka S, Ueo H, Sugimachi K, Akiyoshi T: p27 expression and gastric carcinoma. Nature Med 3:593, 1997","journal-title":"Nature Med"},{"key":"201164_CR83","first-page":"1730","volume":"58","author":"SP Singh","year":"1998","unstructured":"Singh SP, Lipman J, Goldman H, Ellis FH, Aizenman L, Cangi MG, Signoretti S, Chiaur DS, Pagano M, Loda M: Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma. Cancer Research 58:1730-1735, 1998","journal-title":"Cancer Research"},{"key":"201164_CR84","first-page":"3381","volume":"57","author":"V Esposito","year":"1997","unstructured":"Esposito V, Baldi A, De Luca A, Groger AM, Loda M, Giordano GG, Caputi M, Baldi F, Pagano M, Giordano A: Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer. Cancer Res 57:3381-3385, 1997","journal-title":"Cancer Res"},{"key":"201164_CR85","unstructured":"Catzavelos C, Tsao MS, DeBoer G, Bhattacharya N, Shepherd F, Slingerland JM: Reduced expression of the cell cycle inhibitor p27Kip1 in non-small cell lung carcinoma: a potential prognostic factor independent of ras. Submitted, 1998"},{"key":"201164_CR86","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)65572-1","volume":"153","author":"VA Florenes","year":"1998","unstructured":"Florenes VA, Maelandsmo GM, Kerbel RS, Slingerland J, Nesland JM, Holm R: Protein expression of the cell-cycle inhibitor p27Kip1 in malignant melanoma: Inverse correlation with disease-free survival. Am J Pathol 153:305-312, 1998","journal-title":"Am J Pathol"},{"key":"201164_CR87","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.leu.2400581","volume":"11","author":"A Allessandrini","year":"1997","unstructured":"Allessandrini A, Chiaur DS, Pagano M: Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11:342-345, 1997","journal-title":"Leukemia"},{"key":"201164_CR88","first-page":"401","volume":"150","author":"RV Lloyd","year":"1997","unstructured":"Lloyd RV, Jin L, Qian X, Kulig E: Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol 150:401-407, 1997","journal-title":"Am J Pathol"},{"key":"201164_CR89","unstructured":"Jordan R, Bradley G, Slingerland JM: Reduced levels of the cell-cycle inhibitor p27KIP1 in epithelial dysplasia and carcinoma of the oral cavity. Submitted, Am J Pathol, 1998"},{"key":"201164_CR90","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jnci\/85.15.1206","volume":"85","author":"G Gasparini","year":"1993","unstructured":"Gasparini G, Pozza F, Harris AL: Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients. J Natl Cancer Inst 85:1206-1219, 1993","journal-title":"J Natl Cancer Inst"},{"key":"201164_CR91","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1055-3207(18)30420-4","volume":"4","author":"S Masood","year":"1995","unstructured":"Masood S: Prediction of recurrence for advanced breast cancer. Traditional and contemporary pathologic and molecular markers. Surg Oncol Clin N Am 4:601-632, 1995","journal-title":"Surg Oncol Clin N Am"},{"key":"201164_CR92","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00713399","volume":"36","author":"VC Jordan","year":"1995","unstructured":"Jordan VC: \"Studies on the estrogen receptor in breast cancer\" \u2014 20 years as a target for the treatment and prevention of cancer. Breast Cancer Res Treat 36:267-285, 1995","journal-title":"Breast Cancer Res Treat"},{"key":"201164_CR93","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1056\/NEJM199405053301802","volume":"330","author":"HB Muss","year":"1994","unstructured":"Muss HB, Thor AD, Berry DA, Kute T, Liu E, Koerner F, Cirrincione CT, Budman DR, Wood WC, Barcos M, et al: c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancer. N Engl J Med 330:1260-1268, 1994","journal-title":"N Engl J Med"},{"key":"201164_CR94","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1200\/JCO.1992.10.7.1049","volume":"10","author":"BA Gusterson","year":"1992","unstructured":"Gusterson BA, Gelber RD, Goldhirsch A, Price KN, Save-Soderborgh J, Anbazhagan R, Styles J, Rudenstam CM, Golouh R, Reed R, et al: Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group. J Clin Oncol 10:1049-1056, 1992","journal-title":"J Clin Oncol"},{"key":"201164_CR95","unstructured":"Levin MN, Pritchard KI, Bramwell V, et al: A randomized trial of cyclophosphamide, Epirubicin, fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, fluorouracil in post menopausal women with node-negative breast cancer. J Clin Oncol, in press"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006154900130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006154900130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1006154900130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006154900130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:33:25Z","timestamp":1750480405000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006154900130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,11]]},"references-count":95,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[1998,11]]}},"alternative-id":["201164"],"URL":"https:\/\/doi.org\/10.1023\/a:1006154900130","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1998,11]]}}}